Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
Financials
Financial year 2025
BIOPTIS from Vielsalm, company number BE0892450478, closed financial year 2025 with a result of € -10,034 after tax. For that financial year BIOPTIS recorded a gross margin of € -2,076 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € -17,576 to € -10,034. The company made a loss. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 12, 2026.
€ 1.1 million
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -10,034
▲ 43 % less loss than in 2024
Profit after tax over the fiscal year.
€ 21,915
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -292,048.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 18,063
▼ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -18,995 | € -10,490 | € -13,157 | € -2,076 | ▲ € 11,081 |
| Profit after taxes | € -23,290 | € -14,881 | € -17,576 | € -10,034 | ▲ € 7,543 |
| Equity | € 1,084,583 | € 1,069,702 | € 1,052,126 | € 1,055,052 | |
| Total debts | € 43,404 | € 35,366 | € 30,059 | € 18,063 | ▼ 40% |
| Cash | € 29,082 | € 20,049 | € 15,138 | € 21,915 | ▲ 45% |
| Retained profit | € -249,557 | € -264,438 | € -245,054 | € -292,048 | ▼ € 46,994 |
| Balance sheet total | € 1,127,987 | € 1,105,068 | € 1,082,185 | € 1,073,115 | ▼ 1% |
Key figures of BIOPTIS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to BIOPTIS?
What happened at BIOPTIS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 10,034. filed late Source: NBB ↗
- New establishment in Vielsalm. KBO
- Start of the company according to the CBE. KBO
In short
From € 23,290 loss in 2022 to € 10,034 loss in 2025.
Paid € 64 in corporate taxes since 2022.
Management
The stake of ESCO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
BIOPTISBehind BIOPTIS are Jacques KUYPERS, Gérard BLAISE, Didier SERTEYN and Jean-Luc MARTIN. The shares are held by ESCO (11.4%).
Directors
According to the 2025 annual accounts
Jacques KUYPERS
Director
Didier SERTEYN
Director
Jean-Luc MARTIN
Director
Also active at: Fonds et Services Sociaux - Réseau Solidaris, Centre d'Orientation et de Formation, Pont tiers, Solidaris Coopérative, Solidaris Immo
Shareholders
11.4%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Mont-le-Soie 1
6698 Vielsalm
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0892.450.478
- VAT number
- BE 0892.450.478
- Registered office
- Mont-le-Soie 1, 6698 Vielsalm
- Names & denominations
- BIOPTIS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 October 2007
- Peppol
- Active · Active since 7 Jun 2026
- Activities · NACE
Vervaardiging van meet-, controle- en navigatie-instrumenten en -apparatuur
Vervaardiging van niet-elektrische meet-, regel- en controleapparatuur en van niet-elektrische navigatieapparatuur